CAI
CAI
NASDAQ · Biotechnology

Caris Life Sciences Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$18.56
-0.68 (-3.53%)
As of Mar 25, 9:50 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +66.6% upside
Low Target $20.23
Average Target $30.92
High Target $48.05
Current Price $18.56
Current
$18.56
Target
$30.92
$20.23 $30.92 avg $48.05
Scenario Analysis
Bear Case
$20.23
9.0%
Low target
Base Case
$30.92
+66.6%
Avg target
Bull Case
$48.05
+158.9%
High target
Risk/Reward
17.7x
Highly favorable
Price in Context
52-Week High
$42.50
-56.3% from high
52-Week Low
$20.27
+-8.4% from low
50-Day SMA
$25.57
-27.4% vs SMA
RSI (14)
21.6
Oversold
Target vs 52W High
$30.92
-27.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%